Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17

Accesswire May 13, 2022

StageZero Life Sciences, Ltd Announces Corporate Update

Accesswire April 6, 2022

StageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Update

Accesswire April 1, 2022

StageZero Life Sciences Launches AVRT(TM) in the UK

Accesswire March 31, 2022

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Friday April 1

Accesswire March 29, 2022

CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe

Accesswire March 14, 2022

StageZero Life Sciences Announces Closing of CAD$1.87 Million Private Placement with Institutional Investor

Accesswire March 3, 2022

StageZero Life Sciences Announces CAD$1.87 Million Private Placement with Institutional Investor

Accesswire February 28, 2022

StageZero Life Sciences Announces Warrant Extension

Accesswire February 4, 2022

StageZero Life Sciences Announces Formation of Scientific Advisory Board

Accesswire December 14, 2021

StageZero Life Sciences Named a COVID-19 Travel Testing Partner for Aruba

Accesswire December 13, 2021

StageZero Life Sciences, Ltd Announces Appointment of SRCO as Auditors

Accesswire December 10, 2021

StageZero Life Sciences, Ltd Announces Results of Special Meeting

Accesswire December 10, 2021

StageZero Life Sciences Offers BORDERPASS(TM) COVID-19 PCR Test Kits for Travelers

Accesswire December 6, 2021

StageZero Life Sciences Announces Closing of CAD$4.2 Million Private Placement with Institutional Investors

Accesswire November 26, 2021

StageZero Life Sciences Announces CAD$4.2 Million Private Placement with Institutional Investors

Accesswire November 23, 2021

StageZero Life Sciences ARISTOTLE(R) Multi-Cancer Blood Test Now Available in Greater Toronto Area

Accesswire November 22, 2021

StageZero Life Sciences Introduces COVID-19 PCR Testing for Travellers

Caroline Egan  November 19, 2021

StageZero Life Sciences Introduces BORDERPASS(TM) COVID-19 PCR Testing for Travelers

Accesswire November 19, 2021

StageZero Life Sciences Announces Q3 2021 Financial Results

Accesswire November 16, 2021